Companies
/Basic Materials
Chemours Company
$12.09
▼ $0.09 (−0.74%) today
Markets open · 2:33pm ET
Chemours Company (CC) Earnings History & Trends
67%
EPS beat rate
+67.91%
Avg. EPS surprise
Consecutive EPS misses
CC vs Market · 30-day return after each reportCCS&P 500
CC EPS Trend · estimate vs actualEstimateActual
CC Revenue Trend · estimate vs actualEstimateActual
How Often Does Chemours Company Beat Earnings Estimates?
Chemours Company beat EPS estimates in 4 of its last 6 reported quarters.
| Quarter | EPS · est. | Surprise | Revenue · est. | Surprise |
|---|---|---|---|---|
| Q3 2026 Adjusted EPS excludes items included in GAAP diluted EPS of $1.29. These include $150 million received under the PFAS insurance proceeds MOU (recorded as a reduction to SG&A), net litigation-related income of $138 million, a $50 million gain on sales of assets (Kuan Yin land) and $18 million of environmental charges. | $0.21 est. $0.26 | −18.51% | $1.5B est. $1.5B | +0.50% |
| Q2 2026 | $0.42 est. $0.42 | +0.07% | $1.6B est. $1.7B | −3.95% |
| Q1 2026 | $0.05 est. $-0.04 | +223.76% | $1.4B est. $1.4B | −1.28% |
| Q4 2025 | $0.05 est. $0.02 | +192.40% | $1.3B est. $1.3B | +0.05% |
| Q3 2025 | $0.20 est. $0.24 | −17.22% | $1.5B est. $1.5B | −0.20% |
| Q2 2025 | $0.58 est. $0.46 | +26.94% | $1.6B est. $1.6B | +3.08% |
Figures from SEC filings and company reports. Not investment advice.